Tokyo Tape
Sign in
← Oenon Holdings

Half-year report · HY

2533.TEDINET S100YTO3
Period2026-01-01 → 2026-06-30
Filed2026-08-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥43.7bn2026-01-01 → 2026-06-30Cons.Net sales
Revenue¥87.6bn2025-01-01 → 2025-12-31Cons.Net sales (5-year summary)
Revenue¥42.3bn2025-01-01 → 2025-06-30Cons.Net sales
Operating income¥2.6bn2026-01-01 → 2026-06-30Cons.Operating income
Operating income¥2.3bn2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income¥2.6bn2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income¥4.3bn2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax¥2.7bn2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax¥2.5bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss
Net income¥1.9bn2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥55.8bnat 2026-06-30Cons.Assets
Total assets¥59.2bnat 2025-12-31Cons.Assets
Total assets¥53.9bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥27.6bnat 2026-06-30Cons.Liabilities
Total liabilities¥32.3bnat 2025-12-31Cons.Liabilities
Net assets / equity¥28.2bnat 2026-06-30Cons.Net assets
Net assets / equity¥27.0bnat 2025-12-31Cons.Net assets
Net assets / equity¥25.5bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥831mat 2026-06-30Cons.Cash and deposits
Cash and deposits¥884mat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥826mat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥879mat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥797mat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥882mat 2024-12-31vCons.Cash and cash equivalents
Operating cash flow¥35m2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥377m2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.0bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.062026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.722025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥32.572025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.2%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2025-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 39
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30¥5m
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥6m
Enzymatic Medicinereportable segmentrevenue2026-01-01 → 2026-06-30¥3.0bn
Enzymatic Medicinereportable segmentrevenue external2026-01-01 → 2026-06-30¥3.0bn
Enzymatic Medicinereportable segmentsegment profit2026-01-01 → 2026-06-30¥936m
Liquorreportable segmentrevenue2026-01-01 → 2026-06-30¥40.0bn
Liquorreportable segmentrevenue external2026-01-01 → 2026-06-30¥40.0bn
Liquorreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥6m
Liquorreportable segmentsegment profit2026-01-01 → 2026-06-30¥1.2bn
Real Estatereportable segmentrevenue2026-01-01 → 2026-06-30¥665m
Real Estatereportable segmentrevenue external2026-01-01 → 2026-06-30¥665m
Real Estatereportable segmentsegment profit2026-01-01 → 2026-06-30¥396m
—segment totalrevenue2026-01-01 → 2026-06-30¥43.6bn
—segment totalrevenue external2026-01-01 → 2026-06-30¥43.6bn
—segment totalrevenue intersegment2026-01-01 → 2026-06-30¥6m
—segment totalsegment profit2026-01-01 → 2026-06-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥49m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥44m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30¥6m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥17m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥17m
Enzymatic Medicinereportable segmentrevenue2025-01-01 → 2025-06-30¥2.5bn
Enzymatic Medicinereportable segmentrevenue external2025-01-01 → 2025-06-30¥2.5bn
Enzymatic Medicinereportable segmentsegment profit2025-01-01 → 2025-06-30¥568m
Liquorreportable segmentrevenue2025-01-01 → 2025-06-30¥39.1bn
Liquorreportable segmentrevenue external2025-01-01 → 2025-06-30¥39.0bn
Liquorreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥12m
Liquorreportable segmentsegment profit2025-01-01 → 2025-06-30¥1.4bn
Real Estatereportable segmentrevenue2025-01-01 → 2025-06-30¥660m
Real Estatereportable segmentrevenue external2025-01-01 → 2025-06-30¥660m
Real Estatereportable segmentsegment profit2025-01-01 → 2025-06-30¥389m
—segment totalrevenue2025-01-01 → 2025-06-30¥42.2bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥42.2bn
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥12m
—segment totalsegment profit2025-01-01 → 2025-06-30¥2.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 577
ItemContextValueUnit
Proceeds from sales of noncurrent assets inv cfPrior1InterimDuration182000000JPY
Proceeds from sales of noncurrent assets inv cfInterimDuration70000000JPY
Payments for retirement of noncurrent assets inv cfPrior1InterimDuration-27000000JPY
Payments for retirement of noncurrent assets inv cfInterimDuration-78000000JPY
Purchase of investment securities inv cfPrior1InterimDuration-3000000JPY
Purchase of investment securities inv cfInterimDuration-3000000JPY
Proceeds from sales of investment securities inv cfPrior1InterimDuration－JPY
Proceeds from sales of investment securities inv cfInterimDuration28000000JPY
Other net inv cfPrior1InterimDuration-158000000JPY
Other net inv cfInterimDuration-15000000JPY
Net cash provided by used in investment activitiesPrior1InterimDuration-1241000000JPY
Net cash provided by used in investment activitiesInterimDuration-1109000000JPY
Net increase decrease in short term loans payable fin cfPrior1InterimDuration2800000000JPY
Net increase decrease in short term loans payable fin cfInterimDuration2500000000JPY
Repayment of long term loans payable fin cfPrior1InterimDuration-300000000JPY
Repayment of long term loans payable fin cfInterimDuration-300000000JPY
Repayments of finance lease obligations fin cfPrior1InterimDuration-23000000JPY
Repayments of finance lease obligations fin cfInterimDuration-46000000JPY
Purchase of treasury stock fin cfPrior1InterimDuration-357000000JPY
Purchase of treasury stock fin cfInterimDuration-316000000JPY
Cash dividends paid fin cfPrior1InterimDuration-575000000JPY
Cash dividends paid fin cfInterimDuration-626000000JPY
Dividends paid to non controlling interests fin cfPrior1InterimDuration-3000000JPY
Dividends paid to non controlling interests fin cfInterimDuration-3000000JPY
Other net fin cfPrior1InterimDuration-5000000JPY
Other net fin cfInterimDuration-186000000JPY
Net cash provided by used in financing activitiesPrior1InterimDuration1534000000JPY
Net cash provided by used in financing activitiesInterimDuration1021000000JPY
Net increase decrease in cash and cash equivalentsPrior1InterimDuration-85000000JPY
Net increase decrease in cash and cash equivalentsInterimDuration-53000000JPY
Cash and cash equivalentsPrior2YearInstant882000000JPY
Cash and cash equivalentsPrior1YearInstant879000000JPY
Cash and cash equivalentsPrior1InterimInstant797000000JPY
Cash and cash equivalentsInterimInstant826000000JPY
Products freightage and warehousing fee sgaPrior1InterimDuration2075000000JPY
Products freightage and warehousing fee sgaInterimDuration2103000000JPY
Advertising expenses sgaPrior1InterimDuration65000000JPY
Advertising expenses sgaInterimDuration67000000JPY
Promotion expenses sgaPrior1InterimDuration101000000JPY
Promotion expenses sgaInterimDuration105000000JPY
Payroll and allowances sgaPrior1InterimDuration1009000000JPY
Payroll and allowances sgaInterimDuration1055000000JPY
Bonuses sgaPrior1InterimDuration432000000JPY
Bonuses sgaInterimDuration498000000JPY
Provision for directors bonuses sgaPrior1InterimDuration15000000JPY
Provision for directors bonuses sgaInterimDuration19000000JPY
Retirement benefit expenses sgaPrior1InterimDuration86000000JPY
Retirement benefit expenses sgaInterimDuration91000000JPY
Welfare expenses sgaPrior1InterimDuration266000000JPY
Welfare expenses sgaInterimDuration282000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass